← TagsProduct

Lenalidomide

Yellow SolidChEBI: A dicarboximide that consists of 1-oxoisoindoline bearing an amino substituent at position 4 and a 2,6-dioxopiperidin-3-yl group at position 2. Inhibits the secretion of TNF-alpha.Lenalidomide is a derivative of thalidomide differing in the presence of an amino moiety in the 4-position and removal of one of the carbonyls of the phthaloyl ring. While other indications are under evaluation, lenalidomide has initially been launched for the treatment of myelodysplastic syndro

1 articles

India's Cipla misses quarterly profit view on muted US sales

India's Cipla missed Q2 profit estimates as net earnings fell to 8.78 billion rupees due to weak US sales of generic Revlimid. While North American revenue declined 19%, Indian operations grew 12%, pa

reuters · 2026-10-27 00:58

Product Info

Name (EN)	Lenalidomide
CAS No.	191732-72-6
Molecular Formula	C13H13N3O3
HS Code	29339900
Type	product
Application	A Thalidomide analog known to have immunomodulatory properties
Other Names (EN)	2,6-Piperidinedione,3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-;3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione;3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione;Revimid;CC 5013;CDC 501;Lenalidomide;Revlimid;1-Oxo-4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole;3-(4-Amino-1-ox
Description	Yellow SolidChEBI: A dicarboximide that consists of 1-oxoisoindoline bearing an amino substituent at position 4 and a 2,6-dioxopiperidin-3-yl group at position 2. Inhibits the secretion of TNF-alpha.Lenalidomide is a derivative of thalidomide differing in the presence of an amino moiety in the 4-po